Cargando…

A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation

Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarasenko, Tatyana N., Rosas, Odrick R., Singh, Larry N., Kristaponis, Kara, Vernon, Hilary, McGuire, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315515/
https://www.ncbi.nlm.nih.gov/pubmed/25647322
http://dx.doi.org/10.1371/journal.pone.0116594
_version_ 1782355486024138752
author Tarasenko, Tatyana N.
Rosas, Odrick R.
Singh, Larry N.
Kristaponis, Kara
Vernon, Hilary
McGuire, Peter J.
author_facet Tarasenko, Tatyana N.
Rosas, Odrick R.
Singh, Larry N.
Kristaponis, Kara
Vernon, Hilary
McGuire, Peter J.
author_sort Tarasenko, Tatyana N.
collection PubMed
description Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic:polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans.
format Online
Article
Text
id pubmed-4315515
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43155152015-02-13 A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation Tarasenko, Tatyana N. Rosas, Odrick R. Singh, Larry N. Kristaponis, Kara Vernon, Hilary McGuire, Peter J. PLoS One Research Article Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic:polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans. Public Library of Science 2015-02-03 /pmc/articles/PMC4315515/ /pubmed/25647322 http://dx.doi.org/10.1371/journal.pone.0116594 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Tarasenko, Tatyana N.
Rosas, Odrick R.
Singh, Larry N.
Kristaponis, Kara
Vernon, Hilary
McGuire, Peter J.
A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title_full A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title_fullStr A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title_full_unstemmed A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title_short A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
title_sort new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315515/
https://www.ncbi.nlm.nih.gov/pubmed/25647322
http://dx.doi.org/10.1371/journal.pone.0116594
work_keys_str_mv AT tarasenkotatyanan anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT rosasodrickr anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT singhlarryn anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT kristaponiskara anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT vernonhilary anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT mcguirepeterj anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT tarasenkotatyanan newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT rosasodrickr newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT singhlarryn newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT kristaponiskara newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT vernonhilary newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation
AT mcguirepeterj newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation